Vontobel Holding
SUPN icon

Vontobel Holding’s Supernus Pharmaceuticals SUPN Stock Holding History

Vontobel Holding’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$228K Buy
4,419
+70
+2% +$3.56K ﹤0.01% 1076
2025
Q4 		$216K Buy
+4,349
New +$211K ﹤0.01% 1288

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vontobel Holding's SUPN Position: Q1 2026 in Review

Vontobel Holding increased its Supernus Pharmaceuticals (SUPN) stake by 1.6% in Q1 2026, buying an estimated $3.56K and bringing the position to 4,419 shares worth $228K. The position accounts for ﹤0.01% of the portfolio, ranked #1076.

Vontobel Holding first reported a position in SUPN in Q4 2025 and has held it in 2 quarters since. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • Vontobel Holding held 4,419 shares of Supernus Pharmaceuticals worth $228K as of Q1 2026.
  • Vontobel Holding bought 70 Supernus Pharmaceuticals shares in Q1 2026, an estimated $3.56K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Vontobel Holding's portfolio in Q1 2026, its #1076 holding.
  • Vontobel Holding first reported a position in Supernus Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.